Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy. 2011

M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
Department of Neurosciences, Psychiatry and Anaesthesiology, University of Messina, AOU Policlinico, Messina 98125, Italy.

Telomere shortening is thought to contribute to premature senescence of satellite cells in Duchenne muscular dystrophy (DMD) muscle. Telomeric repeat binding factor-1 (TRF1) and poly (ADP-ribose) polymerase-1 (PARP1) are proteins known to modulate telomerase reverse transcriptase (TERT) activity, which controls telomere elongation. Here we show that an age-dependent telomere shortening occurs in DMD muscles and is associated to overexpression of mRNA and protein levels of TRF1 and PARP1. TERT expression and activity are detectable in normal control muscles and they slightly increase in DMD. This is the first demonstration of TRF1 and PARP1 overexpression in DMD muscles. They can be directly involved in replicative senescence of satellite cells and/or in the pathogenetic cascade through a cross-talk with oxidative stress and inflammatory response. Modulation of these events by TRF1 or PARP1 inhibition might represent a novel strategy for treatment of DMD and other muscular dystrophies.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071137 Poly (ADP-Ribose) Polymerase-1 A poly(ADP-ribose) polymerase that contains two ZINC FINGERS in its N-terminal DNA-binding region. It modifies NUCLEAR PROTEINS involved in chromatin architecture and BASE EXCISION REPAIR with POLY ADENOSINE DIPHOSPHATE RIBOSE. NAD+ ADP-ribosyltransferase-1,PARP-1 Protein,PARP1 Protein,Poly (ADP-Ribose) Synthase-1,NAD+ ADP ribosyltransferase 1,PARP 1 Protein
D052097 Quadriceps Muscle The quadriceps femoris. A collective name of the four-headed skeletal muscle of the thigh, comprised of the rectus femoris, vastus intermedius, vastus lateralis, and vastus medialis. Quadriceps Femoris,Rectus Femoris,Vastus Intermedius,Vastus Lateralis,Vastus Medialis,Muscle, Quadriceps,Muscles, Quadriceps,Quadriceps Muscles
D059506 Telomere Shortening The loss of some TELOMERE sequence during DNA REPLICATION of the first several base pairs of a linear DNA molecule; or from DNA DAMAGE. Cells have various mechanisms to restore length (TELOMERE HOMEOSTASIS.) Telomere shortening is involved in the progression of CELL AGING. Shortening, Telomere,Shortenings, Telomere,Telomere Shortenings
D020388 Muscular Dystrophy, Duchenne An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415) Becker Muscular Dystrophy,Duchenne Muscular Dystrophy,Muscular Dystrophy, Becker,Muscular Dystrophy, Pseudohypertrophic,Becker's Muscular Dystrophy,Cardiomyopathy, Dilated, 3B,Cardiomyopathy, Dilated, X-Linked,Childhood Muscular Dystrophy, Pseudohypertrophic,Childhood Pseudohypertrophic Muscular Dystrophy,Duchenne and Becker Muscular Dystrophy,Duchenne-Becker Muscular Dystrophy,Duchenne-Type Progressive Muscular Dystrophy,Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Becker Type,Muscular Dystrophy, Childhood, Pseudohypertrophic,Muscular Dystrophy, Duchenne Type,Muscular Dystrophy, Duchenne and Becker Types,Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type,Muscular Dystrophy, Pseudohypertrophic, Childhood,Progressive Muscular Dystrophy, Duchenne Type,Pseudohypertrophic Childhood Muscular Dystrophy,Pseudohypertrophic Muscular Dystrophy, Childhood,Duchenne Becker Muscular Dystrophy,Duchenne Type Progressive Muscular Dystrophy,Muscular Dystrophy, Becker's,Muscular Dystrophy, Duchenne-Becker,Pseudohypertrophic Muscular Dystrophy

Related Publications

M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
October 2019, American journal of physiology. Cell physiology,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
January 2017, Einstein (Sao Paulo, Brazil),
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
January 1990, Archives of physical medicine and rehabilitation,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
January 1987, Journal of pediatric orthopedics,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
August 2013, Nature cell biology,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
January 2005, The American journal of pathology,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
August 2021, Molecular medicine reports,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
June 1991, Current opinion in genetics & development,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
June 1999, Thorax,
M'Hammed Aguennouz, and Gian Luca Vita, and Sonia Messina, and Annamaria Cama, and Natalia Lanzano, and Annamaria Ciranni, and Carmelo Rodolico, and Rosa Maria Di Giorgio, and Giuseppe Vita
January 2008, Neurology India,
Copied contents to your clipboard!